Restore Therapy & Counseling, Plc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 24 19th St Sw, Sioux Center, IA 51250 Phone: 712-722-5560 |
Renew Counseling Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 418 2nd Ave Ne, Sioux Center, IA 51250 Phone: 712-600-4717 |
Dordt University Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 1124 7th Ave Ne, Sioux Center, IA 51250 Phone: 712-722-4850 |
News Archive
Although "[t]aking substantial steps to reduce the abortion rate will not settle the larger ethical argument over the practice," the "election of a new congressional majority" for the 110th Congress should "open the way for a better approach to the abortion question," Washington Post columnist E.J. Dionne writes in a Post opinion piece.
Nationwide Better Health recently enhanced its workplace benefits offering by adding group short-term and long-term disability plans with flexible features and benefit levels. The company's workplace benefits portfolio, which also include group term life insurance, group dental plans, medical stop loss insurance, business travel accident, and accident/hospital Ca$hBack plans, allow employers to provide benefits that help safeguard their employees' physical and fiscal health.
A team of researchers from the National University of Singapore (NUS) has uncovered the mystery behind the potent parasite-killing effect of artemisinin, a drug that is considered to be the last line of defence against malaria. Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug-resistant parasites.
Tobacco acts as a precipitating factor for headaches, specifically migraines. This is indicated in a study which shows that smokers have more migraine attacks and that smoking more than five cigarettes a day triggers this headache. The work has appeared in The Journal of Headache and Pain.
The Liverpool School of Tropical Medicine (LSTM) together with colleagues at the Department of Chemistry (University of Liverpool (UoL)) and Japanese pharmaceutical company Eisai are pleased to announce that they have been awarded a Global Health Innovative Technology (GHIT) Fund to develop new drugs to target lymphatic filariasis and onchocerciasis.
› Verified 8 days ago